The Effect of Dynamic Neuromuscular Stabilization Exercises in Patients With Lower Extremity Lymphedema
Launched by ISTANBUL UNIVERSITY - CERRAHPASA · Aug 7, 2024
Trial Information
Current as of July 09, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of a specific type of exercise called Dynamic Neuromuscular Stabilization (DNS) on patients with lower limb lymphedema. Lymphedema is a condition that causes swelling due to fluid buildup, and it can make physical activity difficult and lead to balance problems. The goal of this study is to see if DNS exercises can improve balance, movement control, and overall physical function in people who have this condition.
To participate in the trial, individuals must be at least 18 years old and have been diagnosed with lower limb lymphedema. Participants need to be in a specific treatment phase and must agree to take part in the study. Over six weeks, all participants will engage in a home exercise program three days a week, which includes breathing exercises and walking. Those in the intervention group will also do DNS exercises twice a week. Throughout the study, everyone will wear special compression garments to help with their swelling. The findings from this study will help researchers and therapists understand how effective DNS exercises are for improving the lives of individuals with lymphedema.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Being 18 years or older
- • Being diagnosed with lymphedema due to primary or secondary causes in the lower extremity
- • Having progressed to Complex Decongestive Treatment Phase 2
- • Volunteering to participate in research
- Exclusion Criteria:
- • No mental or cognitive problems
- • Not receiving any other concurrent conservative or surgical treatment during the study.
- • Presence of metastatic cancer
- • Having a neurological disorder that may affect balance or an orthopedic disorder that may prevent walking
- • Presence of active infection in the affected limb
- • Uncontrolled hypertension, presence of serious cardiovascular system disease
- • There is a risk of deep vein thrombosis
- • Presence of open skin wound
- • Having a history of falling in the last 3 months
About Istanbul University Cerrahpasa
Istanbul University - Cerrahpasa is a prestigious academic institution renowned for its commitment to advancing medical research and education. With a focus on innovative clinical trials, the university harnesses cutting-edge methodologies to address pressing health challenges. Its collaborative environment fosters interdisciplinary research, enabling the development of effective therapeutic strategies and enhancing patient care. The institution's dedication to ethical standards and patient safety underscores its reputation as a leader in clinical research within the region and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Istanbul, Fatih, Turkey
Istanbul, , Turkey
Istanbul, Büyükçekmece, Turkey
Patients applied
Trial Officials
Büşra Çiftçi, BSc
Principal Investigator
Istanbul University - Cerrahpasa
Rüstem Mustafaoğlu, Assoc Prof D
Principal Investigator
Istanbul University - Cerrahpasa
Teoman Aydın, Prof Dr
Principal Investigator
Bezmialem Vakif University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported